Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial
Characterizing myocardial steatosis and associated potential risk factors among a subset of the REPRIEVE participants
View Publication